Dual-modality imaging demonstrates the enhanced antitumoral effect of herpes simplex virus-thymidine kinase/ganciclovir plus gemcitabine combination therapy on cholangiocarcinoma

Herpes simplex virus-thymidine kinase/ganciclovir (HSV-TK/GCV) therapy is one of the most promising therapeutic strategies for the treatment of cholangiocarcinoma, which is the second most common hepatobiliary cancer. The aim of the present study was to evaluate the enhanced therapeutic effects of H...

Descripción completa

Detalles Bibliográficos
Autores principales: WANG, JIANFENG, LI, ANG, JIN, MEI, ZHANG, FAN, LI, XIAOLING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906843/
https://www.ncbi.nlm.nih.gov/pubmed/27347037
http://dx.doi.org/10.3892/etm.2016.3294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906843/
https://www.ncbi.nlm.nih.gov/pubmed/27347037
http://dx.doi.org/10.3892/etm.2016.3294

Ejemplares similares